Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 953 K1.29 M1.15 M1.29 M1.22 M 4.95 M Research & development ————— — Operating income 802 K-20.66 M-1.29 M-10.48 M-4.4 M -36.84 M Non-Operating Income, Total -393 K-21.25 M-1.68 M-11.37 M-14.58 M -48.89 M Interest expense, net of interest capitalized 6.18 M6.14 M5.78 M5.03 M5 M 21.95 M Non-Operating Income, excl. Interest Expenses -6.58 M-27.4 M-7.46 M-16.4 M-19.58 M -70.84 M Unusual income/expense ————— — Pretax income 5.52 M-16.01 M3.18 M-6.05 M-314 K -19.19 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 4.26 M2.25 M-556 K8.38 M-687 K 9.39 M Discontinued operations ————— — Net income 4.26 M2.25 M-556 K8.38 M-687 K 9.39 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 4.26 M2.25 M-556 K8.38 M-687 K 9.39 M Basic earnings per share (Basic EPS) 0.180.1-0.020.36-0.03 0.41 Diluted earnings per share (Diluted EPS) 0.180.1-0.020.36-0.03 0.41 Average basic shares outstanding 23.24 M23.24 M23.24 M23.17 M22.17 M — Diluted shares outstanding 23.24 M23.24 M23.24 M23.17 M22.17 M — EBITDA 971 K-21.34 M-1.62 M-11.13 M-4.84 M -38.92 M EBIT 802 K-20.66 M-1.29 M-10.48 M-4.4 M -36.84 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) -621 K-677 K-331 K-645 K-437 K -2.09 M